Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting
Bipolar Disorders · 2025
DOI: 10.1111/bdi.70060 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Bipolar Disorders, 2025. Verfasst von Søren L Jacobsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark. Hauptthemen laut MEDLINE: Antimanic Agents, Bipolar Disorder, Lithium, Lithium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lithium blood levels are measured routinely 12 h after lithium dosing, but no study has evaluated the actual compliance of patients with the 12‐h levels.
Methods
First, we used the US multicenter clinical trial “Bipolar CHOICE” ( n = 145 patients treated with lithium with N = 287 lithium blood tests), where participants reported the time since the last lithium dose at lithium blood tests. Second, we included all lithium blood tests (3179 individuals, 52,837 blood tests) from hospitals and private practitioners in the Central Denmark Region (CDR, approximate population 1.3 million) during 2012–2022, including the time of lithium blood tests and the registered time when patients were supposed to take their lithium dose.
Results
In Bipolar CHOICE, participants took the lithium blood test at a mean/median of 12.8/12 h (SD = 9.1, IQR = 10.5–14) after the lithium dose, but the range was 0.5–120 h and 44.9% had the blood test taken < 10 or > 14 h after the lithium dose. Those with a blood test > 14 h after the lithium dose had significantly lower lithium levels (0.41 vs. 0.64). In the CDR, the mean/median time was 14.5/13.7 (SD = 3.8, IQR = 12.0–15.8) and 49.7% had the blood test taken < 10 or > 14 h after the supposed intake of lithium. Those with > 16 h between lithium intake and the lithium blood test were more often followed by general practitioners and showed higher creatinine concentrations.
Conclusions
Approximately half of lithium blood tests do not comply with guideline‐based recommendations for 12‐h trough levels, emphasizing the need for solutions to solve this clinical need.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Departments of Affective Disorders, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.
- Dauten Family Center for Bipolar Disorder Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Søren L Jacobsen, Andrew A Nierenberg
Zitieren
APA
Jacobsen, S. L., Kraft, C. L., Nierenberg, A. A., Devantier, T. A., & Köhler-Forsberg, O. (2025). Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting. Bipolar Disorders. https://doi.org/10.1111/bdi.70060
Vancouver
Jacobsen SL, Kraft CL, Nierenberg AA, Devantier TA, Köhler-Forsberg O. Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting. Bipolar Disorders. 2025. doi:10.1111/bdi.70060
BibTeX
@article{Jacobsen2025,
author = {Jacobsen, Søren L and Kraft, Christian L and Nierenberg, Andrew A and Devantier, Torben A and Köhler-Forsberg, Ole},
title = {Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting},
journal = {Bipolar Disorders},
year = {2025},
doi = {10.1111/bdi.70060}
}
EUVIMED